Last updated: April 12, 2024
Sponsor: National Yang Ming University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Diabetes Prevention
Diabetes And Hypertension
Treatment
SugarCut® Unripe Guava Fruit Extract
Placebo group
Clinical Study ID
NCT06330948
NYCU112183AEF
Ages 20-60 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Adults aged 20-60.
- Fasting blood glucose level is between 100 ~ 126 mg/dL.
Exclusion
Exclusion Criteria:
- Patients with renal insufficiency and kidney dialysis.
- Cancer patients.
- Those taking blood sugar regulation-related drugs.
- Have a history of guava allergy
- People suffering from mental illness
- Pregnant and breastfeeding women
- Long-term use of blood sugar regulating supplements
Study Design
Total Participants: 60
Treatment Group(s): 2
Primary Treatment: SugarCut® Unripe Guava Fruit Extract
Phase:
Study Start date:
April 01, 2024
Estimated Completion Date:
January 31, 2025
Study Description
Connect with a study center
National Yang Ming Chiao Tung University
Taipei, Beitou Dist. 112
TaiwanActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.